Cyclopentenylcytosine - CAS 90597-22-1

Cyclopentenylcytosine (CPC), a nucleoside analog, effectively inhibits CTP synthetase, leading to reduced levels of cytidine triphosphate (CTP) and deoxycytidine triphosphate (dCTP) in leukemic cells. Furthermore, it enhances the phosphorylation of 1-β-D-arabinorubosylmannosylcytidine (araC) and increases its DNA intercalation activity. In the human T lymphocyte line MOLT-3, cyclopentenylcytosine triggers apoptosis and necrosis in a dose (50-300 nM) and time (8-16 h) dependent manner. When used in conjunction with araC, cyclopentenylcytosine augments the induction of both apoptosis and necrosis, amplifying its cytotoxic effects on T lymphoblasts.

Apoptosis, Nucleoside Antimetabolite/Analog, Necroptosis, Influenza Virus, HSV, DNA/RNA Synthesis

DNA Damage/DNA Repair, Microbiology/Virology, Apoptosis, Cell Cycle/Checkpoint

90597-22-1

C10H13N3O4

239.23

O[C@H]1[C@@H](C=C(CO)[C@H]1O)N2C(=O)N=C(N)C=C2

-20°C

Ice Packs

Small Compound